CCR5 promoter polymorphism and HIV-1 disease progression

Lancet

Volumn 352, Issue 9131, 1998, Pages 866-870

  McDermott, David H ^a   Zimmerman, Peter A ^a,d   Guignard, Florence ^a,e   Kleeberger, Cynthia A ^c   Leitman, Susan F ^b   Murphy, Philip M ^a,f  

^a Natl Inst Allerg and Infect Dis

^b NATIONAL INSTITUTES OF HEALTH   (United States)

^c JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^d CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e Serono International SA   (Switzerland)

^f NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR; CHLORAMPHENICOL ACETYLTRANSFERASE; MESSENGER RNA;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ALLELE; ARTICLE; DISEASE COURSE; DNA POLYMORPHISM; GENE FREQUENCY; GENE LOCUS; GENOTYPE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IN VITRO STUDY; NUCLEOTIDE SEQUENCE; PATHOGENESIS; PRIORITY JOURNAL; PROMOTER REGION; RACE DIFFERENCE; REPORTER GENE;

EID: 0032511573     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(98)04158-0     Document Type: Article

References (27)

1. Berger EA. HIV entry and tropism: the chemokine receptor connection. Aids 1997; 11 suppl A: S3-16.
2. Doms RW, Peiper SC. Unwelcomed guests with master keys: how HIV uses chemokine receptors for cellular entry. Virology 1997; 235: 179-90.
3. Dean M, Carrington M, Winkler C, et al. Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene. Hemophilia Growth and Development Study, Multicenter AIDS Cohort Study, Multicenter Hemophilia Cohort Study, San Francisco City Cohort, ALIVE Study [erratum in Science 1996: 1069]. Science 1996; 273: 1856-62.
4. Huang Y, Paxton WA, Wolinsky SM, et al. The role of a mutant CCR5 allele in HIV-1 transmission and disease progression [see comments]. Nat Med 1996; 2: 1240-43.
5. Lui R, Paxton WA, Choe S, et al. Homozygous defect in HIV-1 infection. Cell 1996; 86: 367-77.
6. Samson M, Libert F, Doranz BJ, et al. Resistance to HIV-1 infection in caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene. Nature 1996; 382: 722-25.
7. Zimmerman PA, Buckler WA, Alkhatib G, et al. Inherited resistance to HIV-1 conferred by an inactivating mutation in CC chemokine receptor 5: studies in populations with contrasting clinical phenotypes, defined racial background, and quantified risk. Mol Med 1997; 3: 23-36.
8. Wang B, Palasanthiron P, Zeigler J, Cunningham A, Saksena NK. CCR5-delta 32 gene deletion in HIV-1 infected patients. Lancet 1997; 350: 742.
9. Smith MW, Dean M, Carrington M, Huttley GA, O'Brien SJ. CCR5-delta 32 gene deletion in HIV-1 infected patients. Lancet 1997; 350: 741.
10. O'Brien TR, Winkler C, Dean M, et al. HIV-1 infection in a man homozygous for CCR5 delta 32. Lancet 1997; 349: 1219.
11. Hoffman TL, MacGregor RR, Burger H, Mick R, Doms RW, Collman RG. CCR5 genotypes in sexually active couples discordant for human immunodeficiency virus type 1 infection status. J Infect Dis 1997; 176: 1093-96.
12. Edelstein RE, Arcuino LA, Hughes JP, et al. Risk of mother-to-infant transmission of HIV-1 is not reduced in CCR5/delta32ccr5 heterozygotes. J Acquir Immune Defic Syndr Hum Retrovirol 1997; 16: 243-46.
13. Rousseau CM, Just JJ, Abrams EJ, Casabona J, Stein Z, King MC. CCR5del32 in perinatal HIV-1 infection. J Acquir Immune Defic Syndr Hum Retrovirol 1997; 16: 239-42.
14. Michael NL, Chang G, Louie LG, et al. The role of viral phenotype and CCR-5 gene defects in HIV-1 transmission and disease progression. Nat Med 1997; 3: 338-40.
15. Quillent C, Oberlin E, Braun J, et al. HIV-1-resistance phenotype conferred by combination of two separate inherited mutations of CCR5 gene. Lancet 1998; 351: 14-18.
16. Carrington M, Kissner T, Gerrard B, Ivanov S, O'Brien SJ, Dean M. Novel Alleles of the Chemokine-Receptor Gene CCR5. Am J Hum Genet 1997; 61: 1261-67.
17. Ansari-Lari MA, Liu X-M, Metzker ML, Rut AR, Gibbs RA. The extent of genetic variation in the CCR5 gene. Nat Genet 1997; 16: 221-22.
18. Kostrikis LG, Huang Y, Moore JP, et al. A chemokine receptor CCR2 allele delays HIV-1 disease progression and is associated with a CCR5 promoter polymorphism. Nat Med 1998; 4: 350-53.
19. Smith MW, Dean M, Carrington M, et al. Contrasting genetic influence of CCR2 and CCR5 variants on HIV-1 infection and disease progression. Haemophilia Growth and Development Study (HGDS), Multicenter AIDS Cohort Study (MACS), Multicenter Haemophilia Cohort Study (MHCS), San Francisco City Cohort (SFCC), ALIVE Study. Science 1997; 277: 959-65.
20. Winkler C, Modi W, Smith MW, et al. Genetic restriction of AIDS pathogenesis by an SDF-1 chemokine gene variant. ALIVE Study, Haemophilia Growth and Development Study (HGDS), Multicenter AIDS Cohort Study (MACS), Multicenter Haemophilia Cohort Study (MHCS), San Francisco City Cohort (SFCC). Science 1998; 279: 389-93.
21. Guignard F, Combadiere C, Tiffany HL, Murphy PM, Gene organization and Promoter Function for CC Chemokine Receptor 5 (CCR5). J Immunol 1998; 160: 985-92.
22. Moriuchi H, Moriuchi M, Fauci AS. Cloning and Analysis of the Promoter Region og CCR5, a Coreceptor for HIV-1 Entry. J Immunol 1997; 159: 5441-49.
23. Mummidi S, Ahuja SS, McDaniel BL, Ahuja SK. The human CC chemokine receptor 5 (CCR5) gene. Multiple transcripts with 5′end heterogeneity, dual promoter usage, and evidence for polymorphisms within the regulatory regions and noncoding exons. J Biol Chem 1997; 272: 30662-71.
24. Phair J, Jacobson L, Detels R, et al. Acquired immune deficiency syndrome occurring within 5 years of infection with human immunodeficiency virus type-1: the Multicenter AIDS Cohort Study. J Acquir Immune Defic Syndr 1992; 5: 490-96.
25. Zimmerman PA, Phadke PM, Lee A, et al. Migration of a novel DQA1* allele (DQA1*0502) from African origin to North and South America. Hum Immunol 1995; 43: 233-40.
26. Miller LH, Mason SJ, Clyde DF, McGinniss MH. The resistance factor to plasmodium vivax in blacks. The Duffey-blood-group genotype, FyFy. N Eng J Med 1976; 295: 302-04.
27. Horuk R, Chitnis CE, Darbonne WC, et al. A receptor for the material parasite plasmodium vivax: the erythrocyte chemokine receptor. Science 1993; 261: 1182-84